The objective of the proposed research is to define interactions between mammalian reovirus RNA and cellular proteins that regulate translation of viral genes. Reoviruses are members of the Reoviridae, which includes non-enveloped viruses of eukaryotes containing segmented, double-stranded (ds) RNA genomes. Reovirus mRNAs are capped but lack a 3' poly(A) tail, present on most cellular transcripts. Despite the absence of a poly(A) tract, reovirus mRNAs are efficiently translated, and protein synthesis during reovirus infection is almost exclusively viral in origin. How reoviruses are able to accomplish such extraordinary dominance over the cellular translation machinery is not understood. Therefore, translation of reovirus mRNAs is a particularly interesting model for studies of translational control mechanisms and identification of novel cellular RNA-binding proteins that regulate protein expression. The central hypothesis of this work is that termini of reovirus RNAs play important roles in translational control of viral gene expression and that the mechanism of regulation involves specific interactions between viral nucleotide sequences and cellular RNA-binding proteins.
In Specific Aim 1, cellular proteins that bind terminal nucleotide sequences of reovirus RNA will be identified.
In Specific Aim 2, primary nucleotide sequences and higher-order structures in reovirus RNA important for specific protein binding will be defined.
In Specific Aim 3, the role of terminal nucleotide sequences in translational regulation of reovirus RNA will be elucidated using gain-of-function and loss-of-function approaches. This research will enhance an understanding of key intermolecular interactions that regulate translation of reovirus RNA, lead to the identification of previously unknown cellular RNAinteracting proteins, and contribute new insights into general principles of RNA-protein interactions. This work will be conducted in the context of a scientific environment and training program designed to establish Dr. Chappell as an independent investigator focused on translational regulation by viruses and cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08AI062862-02
Application #
7027677
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Cassetti, Cristina
Project Start
2005-04-01
Project End
2008-03-31
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
2
Fiscal Year
2006
Total Cost
$108,472
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pathology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Ooms, Laura S; Jerome, W Gray; Dermody, Terence S et al. (2012) Reovirus replication protein ?2 influences cell tropism by promoting particle assembly within viral inclusions. J Virol 86:10979-87
Kobayashi, Takeshi; Ooms, Laura S; Ikizler, Mine et al. (2010) An improved reverse genetics system for mammalian orthoreoviruses. Virology 398:194-200
Ooms, Laura S; Kobayashi, Takeshi; Dermody, Terence S et al. (2010) A post-entry step in the mammalian orthoreovirus replication cycle is a determinant of cell tropism. J Biol Chem 285:41604-13
Kobayashi, Takeshi; Ooms, Laura S; Chappell, James D et al. (2009) Identification of functional domains in reovirus replication proteins muNS and mu2. J Virol 83:2892-906
Kobayashi, Takeshi; Antar, Annukka A R; Boehme, Karl W et al. (2007) A plasmid-based reverse genetics system for animal double-stranded RNA viruses. Cell Host Microbe 1:147-57
Kobayashi, Takeshi; Chappell, James D; Danthi, Pranav et al. (2006) Gene-specific inhibition of reovirus replication by RNA interference. J Virol 80:9053-63